Table 4.
Cancer-associated genes of FMRMs
| FMRM# | mRNAs | mRNA# | P-value (adj.) |
|---|---|---|---|
| 3 | CALR, RBP4, VIM, NDUFV2, | 12 | 4.89E-03 - |
| SDCBP, MCTS1, AP2S1, PRPF8, | 2.54E-02 | ||
| COL18A1, AK2, ARNT, RPS15 | |||
| 4 | DNMT1, NF2, RRM2 | 3 | 2.13E-03 - |
| 3.05E-02 | |||
| 5 | CEBPB, DDX39, HSP90AB1, | 8 | 2.01E-03 - |
| MT2A, NUP62, SQLE, TCP1, TRIO | 4.84E-02 | ||
| 11 | DICER1, ENO1, HSP90B1, | 5 | 5.26E-03 - |
| RXRB, SPRY2 | 4.84E-02 | ||
| 13 | IGF2R, LSM14B, NCOR2, SP110, | 14 | 6.88E-03 - |
| STX5, TOR2A, ACHE, HDAC3, | 4.56E-02 | ||
| PARP1, POSTN, SMAD4, UBE2I, | |||
| RNF6, BAK1 |
Many genes identified in FMRMs are relevant to cancers. Genes identified in FMRMs are directly assigned to diseases and disorders. The cancer-related genes of FMRMs within their top five biofunctions are listed.